Smith+Nephew has inked a distribution agreement with SI Bone for the iFuse TORQ portfolio.
The portfolio includes two implants with indications for pelvic fracture fixation and fusion of the SI joint, according to a Feb. 23 news release from Smith+Nephew.
The iFuse TORQ TNT has received the FDA’s breakthrough device designation and is eligible for a Medicare New Technology Add-on Payment.
The partnership expands access to differentiated products, deepens surgeon engagement and drives growth, according to Scott Gunn, vice president trauma, extremities and shoulder at Smith+Nephew.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
